News | December 08, 2023
Operations disrupted at NATCO Pharma's Manali, Chennai factory
NATCO temporarily shut down the operations due to cyclone with flooding/water logging of the factory premises
NATCO temporarily shut down the operations due to cyclone with flooding/water logging of the factory premises
The company is assessing the situation and simultaneously undertaking all the requisite action
The company has received Form 483 with three observations
The full transition of Viatris' biosimilars operations to Biocon Biologics in Europe represents another significant milestone
Both the India and GCC entities will be operated by separate dedicated management teams
Collaboration enables Brenntag to serve pharma customers in EMEA with chromatography silica gels
Phase 3 data expected in the second half of 2024
The company has raised US$4.5 million in funding for its AI operating system
Digitally enabled drug discovery for oncology with potential to accelerate the delivery of new cancer therapies to patients
Q2FY24 EBITDA up by 105% y-o-y at Rs. 28 crore
Subscribe To Our Newsletter & Stay Updated
